Skip to main content
SpringerLink
Log in

Role of Extracorporeal Drug Removal in Acute Theophylline Poisoning

A Review

  • Concepts in Toxicology Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

Theophylline, with its narrow therapeutic margin, is a common cause of iatrogenic and deliberate overdose. Most cases of self-poisoning are with sustained release preparations, with peak concentrations occurring up to 12 or more hours after overdose. Toxic symptoms are often seen at concentrations above 15 mg/L. Theophylline is metabolised within the cytochrome P-450 system, with an average total body clearance of 50 to 60 ml/ min. Clearance is, however, affected by many factors such as other drugs or disease, and in overdose zero order kinetics may result in prolonged half-lives. Toxicity is characterised by agitation, tremor, nausea, vomiting, abdominal pains, seizures, and tachyarrhythmias. Hypokalaemia and metabolic acidosis are more profound in acute toxicity, and hypercalcaemia is usually present. Seizures occur at lower concentrations after chronic over-medication than after acute overdose.

Gastric lavage should be performed in all patients presenting early, and an oral multiple dose charcoal regimen started with 50 to 100g charcoal, repeating with 50g doses and checking theophylline concentrations at 2- to 4-hour intervals. Multiple dose charcoal can be expected to double the clearance of theophylline, being as effective as a haemodialysis. Of the invasive techniques available, charcoal haemoperfusion is the most effective, increasing clearance 4- to 6-fold. Supportive care is particularly important. The aggressive supplementation of potassium, treatment ofemesis with droperidol and ranitidine, and treatment of tachyarrhythmias and hypotension (possibly with propranolol), together with oral multiple dose charcoal may obviate the need for haemoperfusion. Seizures suggest increased morbidity and mortality.

Charcoal haemoperfusion should be considered if plasma concentrations are greater than 100 mg/L in an acute intoxication or greater than 60 mg/L in a chronic intoxication. The decision to haemoperfuse should not be based on plasma concentrations alone, but an overall evaluation of the patient’s laboratory and clinical status. blReferences

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahlmén J, Heath A, Herlitz H, Kvist L, Mellstrand T. Treatment of oral theophylline poisoning. Acta Medica Scandinavica 216: 423–426, 1984

    PubMed  Google Scholar 

  • Alván G, Asaba H, Bergström J, Ekborg L, Odar-Cederlöf I, et al. Akut teofyllin förgiftning behandlad med hemoperfusion och hemodialys i kombination. Läkartidningen 79: 745–746, 1982

    PubMed  Google Scholar 

  • Amin DN, Henry JA. Propranolol administration in theophylline overdose. Lancet 1: 520–521, 1985

    Article  CAS  PubMed  Google Scholar 

  • Amitai Y, Yeung AC, Moye J, Lovejoy FH. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Annals of Internal Medicine 105: 386–387, 1986

    CAS  PubMed  Google Scholar 

  • Arvidsson S, Niemand D, Martineil S, Ekström-Jodal B. Aminophylline reversal of diazepam sedation. Anaesthesia 39: 806–809, 1984

    Article  CAS  PubMed  Google Scholar 

  • Baker MD. Theophylline toxicity in children. Journal of Paediatrics 109: 538–542, 1986

    Article  CAS  Google Scholar 

  • Barnhart JL, Combes B. Effect of theophylline on hepatic excretory function. American Journal of Physiology 227: 194–199, 1974

    CAS  PubMed  Google Scholar 

  • Baselt RC, Albertson TE. Markedly prolonged theophylline half-life in liver failure. Journal of Analytical Toxicology 6: 62–63, 1982

    CAS  PubMed  Google Scholar 

  • Bazilinski N. Aminophylline intoxication. International Journal of Artificial Organs 6: 225–226, 1983

    CAS  PubMed  Google Scholar 

  • Berlinger WG, Spector R, Goldberg MJ, Johnson GF, Quee CK, et al. Enhancement of theophylline clearance by oral activated charcoal. Clinical Pharmacology and Therapeutics 33: 351–354, 1983

    Article  CAS  PubMed  Google Scholar 

  • Biberstein MP, Ziegler MG, Ward DM. Use of β-blockade and hemoperfusion for acute theophylline poisoning. Western Journal of Medicine 141: 485–490, 1984

    CAS  PubMed  Google Scholar 

  • Blye E, Lorch J, Cortell S. Extracorporeal therapy in the treatment of intoxication. American Journal of Kidney Diseases 3: 321–338, 1984

    CAS  PubMed  Google Scholar 

  • Boldy DAR, Buckley BM, Vale JA. Advances in the treatment of poisoning. Journal of Clinical and Hospital Pharmacy 9: 147–160, 1984

    CAS  PubMed  Google Scholar 

  • Brown GS, Lohr TO, Mayor GH, Freitag JJ, Sanchez TV, et al. Peritoneal clearance of theophylline. American Journal of Kidney Diseases 1: 24–26, 1981

    CAS  PubMed  Google Scholar 

  • Buckley BM, Braithwaite RA, Vale JA. Theophylline poisoning. Lancet 2: 618, 1983

    Article  CAS  PubMed  Google Scholar 

  • Burgan THS, Gupta I, Bate CM. Fatal overdose of theophylline simulating acute pancreatitis. British Medical Journal 284: 939–940, 1982

    Article  CAS  PubMed  Google Scholar 

  • Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finlay PR. Cimetidine decreases theophylline clearance. Annals of Internal Medicine 95: 68–69, 1981

    CAS  PubMed  Google Scholar 

  • Cereda J-M, Scott J, Quigley EMM. Endoscopic removal of pharmacobezoar of slow release theophylline. British Medical Journal 293: 1143, 1986

    Article  CAS  PubMed  Google Scholar 

  • Chang TMS, Espinosa-Melendez E, Francoeur TE, Eaade NR. Albumin-colloidion activated charcoal hemoperfusion in the treatment of severe theophylline intoxication in a 3-year old patient. Pediatrics 65: 811–814, 1980

    CAS  PubMed  Google Scholar 

  • Chin L, Picchioni AL, Gillespie T. Saline cathartics and saline cathartics plus activated charcoal as antidotal treatments. Clinical Toxicology 18(7): 865–871, 1981

    Article  CAS  PubMed  Google Scholar 

  • Connell JMC, McGeachie JF, Knepil J, Thomson A, Junor B. Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion. British Medical Journal 284: 943, 1982

    Article  CAS  PubMed  Google Scholar 

  • Conrad KA, Nyman DW. Effects of metoprolol and propranolol on theophylline elimination. Clinical Pharmacology and Therapeutics 28: 463–467, 1980

    Article  CAS  PubMed  Google Scholar 

  • Cooney DO. In vitro evidence for ipecac inactivation by activated charcoal. Journal of Pharmaceutical Sciences 67: 426–427, 1978

    Article  CAS  PubMed  Google Scholar 

  • Corser BC, Youngs C, Baughman RP. Prolonged toxicity following massive ingestion of sustained release theophylline preparation. Chest 88: 749–750, 1985

    Article  CAS  PubMed  Google Scholar 

  • Coupe M. Self-poisoning with sustained release aminophylline: a mechanism for observed secondary rise in serum theophylline. Human Toxicology 5: 341–342, 1986

    Article  CAS  PubMed  Google Scholar 

  • Creger RJ, Ball WD, Bahnte MF. Dose dependent theophylline elimination in an adult. Drug Intelligence and Clinical Pharmacy 17: 202–204, 1983

    CAS  PubMed  Google Scholar 

  • Dean LS, Brown JW. Massive theophylline overdose. Journal of the American Medical Association 248: 1742, 1982

    Article  CAS  PubMed  Google Scholar 

  • de Broe ME, Bismuth C, de Groot G, Heath A, Okonek S, et al. Haemoperfusion; a useful therapy for a severely poisoned patient? Human Toxicology 5: 11–14, 1986

    Article  PubMed  Google Scholar 

  • Devaux AM, Leluyer B, Corbery F, Pierre G, Ensel P. Intoxication massive par la théophylline chez un enfant. Presse Medicale 12: 1998–1999, 1983

    CAS  Google Scholar 

  • Editorial. Self-poisoning with theophylline. Lancet 1: 146–147, 1985

    Google Scholar 

  • Ehlers SM, Zaske DE, Sawchuk RJ. Massive theophylline overdose: rapid elimination by charcoal hemoperfusion. Journal of the American Medical Association 240: 474–475, 1978

    Article  CAS  PubMed  Google Scholar 

  • Emonds EJG, Driessen OMJ. Treatment of theophylline intoxication: a model study utilizing peritoneal dialysis. Clinical Toxicology 13: 505–511, 1978

    Article  CAS  PubMed  Google Scholar 

  • Farley TA. Severe hypernatraemic dehydration after use of an activated charcoal sorbitol suspension. Journal of Paediatrics 109: 719, 1986

    Article  CAS  Google Scholar 

  • Foster LJ, Trudeau WL, Goldman AL. Bronchodilator effects on gastric acid secretion. Journal of the American Medical Association 241: 2613–2615, 1979

    Article  CAS  PubMed  Google Scholar 

  • Gal P, Miller A, McCue JD. Oral activated charcoal to enhance theophylline elimination in an acute overdose. Journal of American Medical Association 251: 3130–3131, 1984

    Article  CAS  Google Scholar 

  • Garella S. Hemoperfusion in treatment of theophylline intoxication. Correspondence American Journal of Medicine 77: A105, 1984

    CAS  Google Scholar 

  • Garella S, Lorch JA. Hemoperfusion for acute intoxication: con. Clinical Toxicology 17: 515–527, 1980

    Article  CAS  PubMed  Google Scholar 

  • Gaudreault P, Guay J. Theophylline poisoning: Pharmacological considerations and clinical management. Medical Toxicology 1: 169–191, 1986

    CAS  PubMed  Google Scholar 

  • Gaudreault P, Lovejoy FH. Treatment of theophylline overdose. Correspondence. Journal of Pediatrics 103: 1004, 1983

    Google Scholar 

  • Gaudreault P, Wason S, Lovejoy FH. Acute pediatric theophylline overdose: a summary of 28 cases. Journal of Pediatrics 102: 474–476, 1983

    Article  CAS  PubMed  Google Scholar 

  • Gelfand MC, Winchester JF. Hemoperfusion in drug overdose: a technique when conservative management is not sufficient. Clinical Toxicology 17: 583–602, 1980

    Article  CAS  PubMed  Google Scholar 

  • Greenberg A, Piraino BH, Kroboth PD, Weiss J. Severe theophylline toxicity: role of conservative measures, antiarrhythmic agents and charcoal hemoperfusion. American Journal of Medicine 76: 854–860, 1984

    Article  CAS  PubMed  Google Scholar 

  • Hall KW, Dobson KE, Dalton JG, Ghignone MC, Penner SB. Metabolic abnormalities associated with intentional theophylline overdose. Annals of Internal Medicine 101: 457–462, 1984

    CAS  PubMed  Google Scholar 

  • Heath A. Pharmacokinetic evaluation of forced diuresis, dialysis, and hemoperfusion. mberset al. (Eds) New concepts and developments in toxicology, pp. 339–345, Elsevier Press, Amsterdam, 1986

    Google Scholar 

  • Helliwell M, Berry D. Theophylline poisoning in adults. British Medical Journal 2: 1114, 1979

    Article  CAS  PubMed  Google Scholar 

  • Helliwell M, Berry D. Theophylline absorption by effervescent activated charcoal (Medicoal). Journal of International Medical Research 9: 222–225, 1981

    CAS  PubMed  Google Scholar 

  • Hendeles L, Massanari M, Weinberger M. Update on the pharmacodynamics and pharmacokinetics of theophylline. Chest 88: 103S–111S, 1985

    CAS  PubMed  Google Scholar 

  • Jacobs MH, Senior RM, Kessler G. Clinical experience with theophylline — relationships between dosage, serum concentration and toxicity. Journal of the American Medical Association 235: 1983–1986, 1976

    Article  CAS  PubMed  Google Scholar 

  • Jeffreys DB, Raper SM, Helliwell M, Berry DJ, Crome P. Haemoperfusion for theophylline overdose. British Medical Journal 1: 1167, 1980

    Article  Google Scholar 

  • Kearney TE, Manoguerra AS, Curtis GP, Ziegler MG. Theophylline toxicity and the β-adrenergic system. Annals of Internal Medicine 102: 766–769. 1985

    CAS  PubMed  Google Scholar 

  • Kossoy AF, Weir MR, Bryant MV. Theophylline toxicity. Paediatrics 72: 746–747, 1983

    CAS  Google Scholar 

  • Laggner AN, Kaik G, Lenz K. Druml W, Kleinberger G. Treatment of severe poisoning with slow release theophylline. British Medical Journal I: 288: 1497, 1984

    CAS  Google Scholar 

  • Lambert M, Mahieu P, Hassoun A, Jacmin. About three cases of acute theophylline intoxication: clinical, toxicological and pharmacokinetic studies. Acta Clinica Belgica 36: 30–36, 1981

    CAS  PubMed  Google Scholar 

  • Lawless LM. Comment on theophylline overdose. Drug Intelligence and Clinical Pharmacy 15: 215, 1981

    CAS  PubMed  Google Scholar 

  • Lawyer C, Aitchinson J, Sutton J, Bennet W. Treatment of theophylline neurotoxicity with resin hemoperfusion. Annals of Internal Medicine 88: 516–517, 1978

    CAS  PubMed  Google Scholar 

  • Lee CS, Marbury TC, Perrin JH, Fuller TJ. Hemodialysis of theophylline in uremic patients. Journal of Clinical Pharmacology, 19: 219–226, 1979

    CAS  PubMed  Google Scholar 

  • Lesko LJ. Dose dependant elimination kinetics of theophylline. Clinical Pharmacokinetics 4: 449–459, 1979

    Article  CAS  PubMed  Google Scholar 

  • Levy G, Gibson TP, Whitman W, Procknal J. Hemodialysis clearance of theophylline. Journal of the American Medical Association 237: 1466–1467, 1977 auLindén CH. The use of propranolol in asthmatics with acute theophylline poisoning. Abstract. Veterinary and Human Toxicology, in press, 1986

    Article  CAS  PubMed  Google Scholar 

  • Lorch JA, Garella S. Hemoperfusion to treat intoxications. Annals of Internal Medicine 91: 301–304, 1979

    CAS  PubMed  Google Scholar 

  • MacDonald JB, Jones HM, Cowan RA. Rhabdomyolysis and acute renal failure after theophylline overdose. Lancet 1: 932–933, 1985

    Article  CAS  PubMed  Google Scholar 

  • Mack RB. Beware of the xanthines bearing gifts: theophylline overdose. North Carolina Medical Journal 45: 437–439, 1984

    Google Scholar 

  • Mahutte CK, True RJ, Michiels TM, Berman JM, Light RW. Increased serum theophylline clearance with oral charcoal. American Review of Respiratory Disease 128: 820–822, 1983

    CAS  PubMed  Google Scholar 

  • McPherson ML, Prince SR, Atmaer ER, Maxwell DB, Ross-Clunis H, et al. Theophylline induced hyperkalemia. Annals of Internal Medicine 105: 52–54, 1986

    CAS  PubMed  Google Scholar 

  • Mayersohn M, Perrier D, Picchioni AL. Evaluation of a charcoalsorbitol mixture as an antidote for oral aspirin overdose. Clinical Toxicology 11: 561–567, 1977

    Article  CAS  PubMed  Google Scholar 

  • Mellstrand T, Svedmyr N, Fagerström P-O. Absorption of theophylline from conventional and sustained release tablets. European Journal of Respiratory Diseases 61 (Suppl. 109): 54–61, 1980

    Google Scholar 

  • Merrill GA. Aminophylline deaths. Journal of the American Medical Association 123: 1115, 1943

    Article  Google Scholar 

  • Miceli JN, Clay B, Fleischmann LE, Sarniak AP, Aronow R, et al. The pharmacokinetics of severe theophylline intoxication managed by peritoneal dialysis. Developmental Pharmacology and Therapeutics 1: 16–25, 1980

    CAS  PubMed  Google Scholar 

  • Modi KB, Horn EH, Bryson SM. Theophylline poisoning and rhabdomyolysis. Lancet 2: 160–161, 1985

    Article  CAS  PubMed  Google Scholar 

  • Mountain RD, Neff TA. Oral theophylline intoxication: a serious error of patient and physician understanding. Archives of Internal Medicine 144: 724–727, 1984

    Article  CAS  PubMed  Google Scholar 

  • Muir KT, Pond SM. Removal of theophylline from the body by hemoperfusion. Clinical Pharmacokinetics 4: 320–321, 1979

    Article  CAS  PubMed  Google Scholar 

  • Neter J, Wasserman W. Applied linear statistical models, pp. 329–334, Irwin, Inc, Homewood, Illinois, 1974

    Google Scholar 

  • Neuvonen PJ. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clinical Pharmacokinetics 7: 465–489, 1982

    Article  CAS  PubMed  Google Scholar 

  • Neuvonen PJ, Olkkola KT. Effect of purgatives on antidotal efficacy of oral activated charcoal. Human Toxicology 5: 255–263, 1986

    Article  CAS  PubMed  Google Scholar 

  • Neuvonen PJ, Tokola O, Vartiainen M. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Clinical Pharmacology and Therapeutics 31: 255–256, 1982

    Google Scholar 

  • Ogilvie RI. Clinical pharmacokinetics of theophylline. Clinical Pharmacokinetics 3: 267–293, 1978

    Article  CAS  PubMed  Google Scholar 

  • Olson KR, Benowitz NL, Woo OF, Pond SM. Theophylline overdose: acute single ingestion versus chronic repeated medication. American Journal of Emergency Medicine 3: 386–394, 1985

    Article  CAS  PubMed  Google Scholar 

  • Olson KR, Pond SM, Benowitz NL, Becker CE. Treatment of theophylline overdose. Journal of the American Medical Association 249: 3176, 1983

    Article  CAS  PubMed  Google Scholar 

  • Park GD, Radomski L, Goldberg MJ, Spector R, Johnson GF, et al. Effect of size and frequency of multiple oral charcoal doses on theophylline clearance. Clinical Pharmacology and Therapeutics 34: 663–666, 1983a

    Article  CAS  PubMed  Google Scholar 

  • Park GD, Spector R, Roberts JJ, Goldberg MJ, Weisman D, et al. Use of hemoperfusion for treatment of theophylline intoxication. American Journal of Medicine 74: 961–966, 1983b

    Article  CAS  PubMed  Google Scholar 

  • Pedersen H, Horvath C. Pharmacokinetic characterization of extracorporeal therapy. Journal of Pharmacokinetics and Biopharmaceutics 10: 437–454, 1982

    CAS  PubMed  Google Scholar 

  • Picchioni AL, Chin L, Gillespie T. Evaluation of activated charcoal-sorbitol suspension as an antidote. Journal of Toxicology — Clinical Toxicology 19: 433–444, 1982

    Article  CAS  PubMed  Google Scholar 

  • Pond SM. Role of repeated oral doses of activated charcoal in clinical toxicology. Medical Toxicology 1: 3–11, 1986

    CAS  PubMed  Google Scholar 

  • Pond SM, Rosenberg J, Benowitz NL, Takki S. Pharmacokinetics of haemoperfusion for drug overdose. Clinical Pharmacokinetics 4: 329–354, 1979

    Article  CAS  PubMed  Google Scholar 

  • Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN. Inhibition of theophylline clearance by cimetidine and not ranitidine. Archives of Internal Medicine 144: 484–486, 1984

    Article  CAS  PubMed  Google Scholar 

  • Radomski L, Park GD, Goldberg JJ, Spector R, Johnson GF, et al. Model for theophylline overdose: treatment with oral activated charcoal. Clinical Pharmacology and Therapeutics 35: 402–408, 1984

    Article  CAS  PubMed  Google Scholar 

  • Reitberg DP, Bernard H, Schentag JJ. Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Annals of Internal Medicine 95: 582–585, 1981

    CAS  PubMed  Google Scholar 

  • Roberts RK, Grice J, Wood L, Petroff V, McGuffie C. Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19–21, 1981

    CAS  PubMed  Google Scholar 

  • Rumpf KW, Wagner H, Criee C-P, Schwarck H, Klein H, et al. Rhabdomyolysis after theophylline overdose. Lancet 1: 1451–1452, 1985

    Article  CAS  PubMed  Google Scholar 

  • Russo ME. Management of theophylline intoxication with charcoal-column hemoperfusion. New England Journal of Medicine 300: 24–26, 1979

    Article  CAS  PubMed  Google Scholar 

  • Rygnestad T, Walstad RA, Dahl K. Self-poisoning with theophylline: the effect of repeated doses of activated charcoal on drug elimination. Acta Medica Scandinavica 219: 425–427, 1986

    Article  CAS  PubMed  Google Scholar 

  • Sahney S, Abarzua I, Sessuns L. Hemoperfusion for theophylline neurotoxicity. Pediatrics 71: 615–619, 1983

    CAS  PubMed  Google Scholar 

  • Sarrazin E, Hendeles L, Weinberger M. Muir K, Riegelman S. Dose-dependant kinetics for theophylline. Observations among ambulatory asthmatic children. Journal of Pediatrics 97: 825–828, 1980

    CAS  Google Scholar 

  • Sawyer WT, Caravati EM, Ellison MJ, Kreuger KA. Hypokalemia, hyperglycemia and acidosis after intentional theophylline overdose. American Journal of Emergency Medicine 3: 408–411, 1985

    Article  CAS  PubMed  Google Scholar 

  • Sessler CN, Glauser FL, Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest 87(3): 325–329, 1985

    Article  CAS  PubMed  Google Scholar 

  • Shen DD, Fixley M, Azarnoff DL. Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms. Journal of Pharmaceutical Science 67: 916–919, 1978

    Article  CAS  Google Scholar 

  • Simons FER, Friesen FR, Simons KJ. Theophylline toxicity in term infants. American Journal of Diseases of Children 134: 39–41, 1980

    CAS  PubMed  Google Scholar 

  • Sintek C, Hendeles L, Weinberger M. Inhibition of theophylline absorption by activated charcoal. Journal of Pediatrics 94: 314–316, 1979

    Article  CAS  PubMed  Google Scholar 

  • Sketris IS, Mowry JB, Czajka PA, Anderson WH, Stafford DT. Saline cathartics: effect on aspirin bioavailability in combination with activated charcoal. Journal of Clinical Pharmacology 22: 59–64, 1982

    CAS  PubMed  Google Scholar 

  • Struthers AD, Elliott HL, Addis GJ. Self-poisoning with sustained release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusion. British Medical Journal 284: 1709, 1982

    Article  CAS  PubMed  Google Scholar 

  • Tandberg D, Diven BG, McLeod JW. Ipecac-induced emesis vs gastric lavage: a controlled study in normal adults. American Journal of Emergency Medicine 4: 205–209, 1986

    CAS  PubMed  Google Scholar 

  • True RJ, Berman JM, Mahutte CK. Treatment of theophylline toxicity with oral activated charcoal. Critical Care Medicine 12: 113–114, 1984

    Article  CAS  PubMed  Google Scholar 

  • Uprichard AC, Bailie R, McAteer E. Management of severe theophylline overdosage by charcoal haemoperfusion. Ulster Medical Journal 53: 159–161, 1984

    CAS  PubMed  Google Scholar 

  • Vale JA, Meredith TJ, Proudfoot AT. Syrup of ipecacuanha: is it really useful? British Medical Journal 293: 1321, 1986

    Article  CAS  PubMed  Google Scholar 

  • van de Graaff WB, Leigh Thompson W, Sunshine I, Fretthold D, Leickly F, et al. Absorbent and cathartic inhibition of enteral drug absorption. Journal of Pharmacology and Experimental Therapeutics 221: 656–663, 1982

    PubMed  Google Scholar 

  • van Kesteren RG, van Dijk A, Klein SW, van Heijst ANP. Massive theophylline intoxication: effects of charcoal haemoperfusion on plasma erythrocyte and theophylline concentrations. Human Toxicology 4: 127–134, 1985

    Article  PubMed  Google Scholar 

  • Wagner JC, Sklar SJ. Comment and case report on dose dependant theophylline elimination. Drug Intelligence and Clinical Pharmacy 17: 847, 1983

    CAS  PubMed  Google Scholar 

  • Walson PD, Jones P. Theophylline overdose treated with propranolol. Veterinary and Human Toxicology 25 (Suppl. 1): 69, 1983

    Google Scholar 

  • Weinberger M. Treatment of theophylline overdose. Journal of Pediatrics 103: 1004, 1983

    CAS  PubMed  Google Scholar 

  • Weinberger M. Theophylline poisoning. Pediatrics 73: 878, 1984

    CAS  PubMed  Google Scholar 

  • Weinberger M, Gichansky E. Dose-dependant kinetics of theophylline disposition in asthmatic children. Journal of Pediatrics 91: 820–824, 1977

    Article  CAS  PubMed  Google Scholar 

  • Weinberger M, Hendeles L. Role of dialysis in the management and prevention of theophylline toxicity. Developmental Pharmacology and Therapeutics 1: 26–30, 1980

    CAS  PubMed  Google Scholar 

  • Wheeler-Usher DH, Wanke LA, Bayer MJ. Gastric emptying: risk versus benefit in the treatment of acute poisoning. Medical Toxicology 1: 142–153, 1986

    CAS  PubMed  Google Scholar 

  • Whyte KF, Addis GJ. Treatment of theophylline poisoning. British Medical Journal 288: 1835, 1984

    Article  CAS  PubMed  Google Scholar 

  • Winchester JF. Active methods for detoxification: oral sorbents, forced diuretics, hemoperfusion and hemodialysis. In Haddad & Winchester (Eds) Clinical management of poisoning and drug overdose, pp. 165, Saunders, Philadelphia, 1983

    Google Scholar 

  • Wolff ED, Driessen OMJ. End kind met theofylline-vergiftiging. Nederlands Tijdschrift voor Geneeskunde 121: 896–899, 1977

    CAS  PubMed  Google Scholar 

  • Woodcock AA, Johnson MA, Geddes DM. Theophylline prescribing, serum concentrations, and toxicity. Lancet 2: 610–613, 1983

    Article  CAS  PubMed  Google Scholar 

  • Zwillich CW, Sutton FD, Neff TA, Cohn WM, Matthay RA, et al. Theophylline induced seizures in adults: correlation with serum concentrations. Annals of Internal Medicine 82: 784–787, 1975

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Poisons Therapy Group, Department of Anaesthesia and Intensive Care, Sahlgren’s Hospital, S-413 45, Göteborg, Sweden

    Andrew Heath (Associate Professor) & Kai Knudsen

Authors
  1. Andrew Heath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Knudsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heath, A., Knudsen, K. Role of Extracorporeal Drug Removal in Acute Theophylline Poisoning. Med Toxicol Adverse Drug Exp 2, 294–308 (1987). https://doi.org/10.1007/BF03259871

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259871

Keywords

Search

Navigation